Integra LifeSciences Holdings
Ownership
Ownership Structure
Who owns Integra LifeSciences Holdings (IART)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 75.4% of the shares are freely tradable; institutional investors hold 100.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 13.74 | 10,684,103 | +3.5 | 06/30/2026 |
| Rubric Capital Management LP | 9.97 | 7,753,934 | +0.0 | 06/30/2026 |
| Amvescap Plc. | 4.82 | 3,749,367 | +7.6 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 4.81 | 3,743,093 | +1.5 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 4.62 | 3,593,079 | +0.2 | 06/30/2026 |
| Paradigm Capital Management, Inc. | 4.42 | 3,439,098 | -14.3 | 06/30/2026 |
| Fuller & Thaler Asset Management Inc | 4.42 | 3,436,006 | -2.6 | 06/30/2026 |
| State Street Corp | 3.79 | 2,946,862 | +2.1 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.06 | 3,933,696 | +0.0 | 09/30/2026 |
| Invesco Small Cap Value A | 4.63 | 3,602,526 | +6.3 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Veillon-Berteloot Chantal | EVP & CHRO | 20,772 | 292,885 $ | Sep 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Veillon-Berteloot Chantal | EVP & CHRO | Other | 1,455 | 16.62 | 24,182 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.